tiprankstipranks
Plus Therapeutics CMO Dr. LaFrance Resignation Announced
Company Announcements

Plus Therapeutics CMO Dr. LaFrance Resignation Announced

Stay Ahead of the Market:

Plus Therapeutics (PSTV) has shared an update.

Plus Therapeutics, Inc. is set to experience a change in its executive team as Dr. Norman LaFrance, the Chief Medical Officer, has tendered his resignation, which will take effect on June 12, 2024.

Find detailed analytics on PSTV stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPlus Therapeutics presented data on ReSPECT-LM Phase 1 trial
TheFlyPlus Therapeutics expands strategic agreement with Telix IsoTherapeutics
TheFlyPlus Therapeutics presents updated progress from its ReSPECT-LM Phase 1 trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App